Christopher Kiritsy

Insider Reports History

Signature
By: Kathleen A. McGowan For: Christopher Kiritsy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Kiritsy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PIERIS PHARMACEUTICALS, INC. Director Stock Option (right to buy) 24.7K Dec 13, 2024 Direct
PALVELLA THERAPEUTICS, INC. Director Non-Qualified Stock Option (right to buy) 12.4K Jun 10, 2025 Direct
HTG MOLECULAR DIAGNOSTICS, INC Director Stock Option (right to buy) 4K Sep 15, 2022 Direct

Insider Reports Filed by Christopher Kiritsy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PVLA PALVELLA THERAPEUTICS, INC. Jun 10, 2025 1 $0 4 Jun 11, 2025 Director
PVLA PALVELLA THERAPEUTICS, INC. Dec 13, 2024 1 $0 4 Dec 17, 2024 Director
PIRS PIERIS PHARMACEUTICALS, INC. Dec 2, 2024 1 $0 4 Dec 9, 2024 Director
PIRS PIERIS PHARMACEUTICALS, INC. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
PIRS PIERIS PHARMACEUTICALS, INC. May 25, 2023 1 $8.5K 4 May 30, 2023 Director
HTGMQ HTG MOLECULAR DIAGNOSTICS, INC Sep 15, 2022 1 $0 4 Sep 15, 2022 Director
PIRS PIERIS PHARMACEUTICALS, INC. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
HTGMQ HTG MOLECULAR DIAGNOSTICS, INC Jan 27, 2022 1 $0 4 Jan 31, 2022 Director
HTGMQ HTG MOLECULAR DIAGNOSTICS, INC Jan 27, 2022 0 $0 3 Jan 31, 2022 Director
PIRS PIERIS PHARMACEUTICALS, INC. Jun 25, 2021 1 $0 4 Jun 29, 2021 Director